For Pimozide, although it is mainly considered a psychiatric drug for the treatment of psychiatric disorders [46], its binding to cyclooxygenase 1 (PTGS1) can reach −10.7 kcal/mol based on our predictive modeling, implying that there may be a strong interaction between the two, which deserves further experimental validation. Here, PTGS1 is linked to psychiatric disorder.